SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
4.180
+0.020 (0.48%)
Oct 8, 2025, 11:50 AM EDT - Market open
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $282.48 million as of October 8, 2025. Its market cap has increased by 11.40% in one year.
Market Cap
282.48M
Enterprise Value
250.12M
1-Year Change
11.40%
Ranking
Category
Stock Price
$4.18
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $282.48M, a decrease of -74.79%. That is a compound annual growth rate of -27.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 281.13M | 37.83% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
| Jul 23, 2021 | 1.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |